As GLP1s boom, dietician startups Berry Street, Fay each nab $50M rounds

​[[{“value”:”

For decades, the US healthcare system has struggled to address the diet-related chronic illnesses affecting nearly half of all adults. That changed in recent years with the discovery of Ozempic and other GLP-1 drugs that help people lose weight. While insurance covers these medications, doctors frequently require patients to see a nutritionist as part of […]

© 2024 TechCrunch. All rights reserved. For personal use only.

“}]]